These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 223026)

  • 1. Plasma protein regulation of platelet function and metabolism.
    Hansen MS; Bang NU
    Mol Cell Biochem; 1979 Apr; 24(3):143-58. PubMed ID: 223026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of plasma proteins on human platelet metabolism.
    Hansen MS; Bang NU
    Thromb Res; 1979 Jan; 14(1):131-46. PubMed ID: 85347
    [No Abstract]   [Full Text] [Related]  

  • 3. Gel-filtered human platelets. Ultrastructure, function, and role of proteins in inhibition of aggregation by aspirin.
    Fine KM; Ashbrook PC; Brigden LP; Maldonado JE; Didishelm P
    Am J Pathol; 1976 Jul; 84(1):11-24. PubMed ID: 59550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and function of human platelets washed by albumin density gradient separation.
    Walsh PN; Mills DC; White JG
    Br J Haematol; 1977 Jun; 36(2):287-96. PubMed ID: 871437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of two distinct adenosine diphosphate receptors in human platelets.
    Colman RW; Figures WR; Colman RF; Morinelli TA; Niewiarowski S; Mills DC
    Trans Assoc Am Physicians; 1980; 93():305-16. PubMed ID: 6264660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors responsible for ADP-induced release reaction of human platelets.
    Mustard JF; Perry DW; Kinlough-Rathbone RL; Packham MA
    Am J Physiol; 1975 Jun; 228(6):1757-65. PubMed ID: 50744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man].
    Ardelt W
    Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
    Zucker MB; Mauss EA
    Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
    Weber AA; Reimann S; Schrör K
    Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives.
    Peerschke EI; Galanakis DK
    J Lab Clin Med; 1983 Mar; 101(3):453-60. PubMed ID: 6827176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of platelet arachidonic acid oxygenation by cyclic AMP.
    Schafer AI; Levine S; Handin RI
    Blood; 1980 Nov; 56(5):853-8. PubMed ID: 6252992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-induced increase in intracellular cyclic 3',5'-adenosine monophosphate in human platelets.
    Droller MJ; Wolfe SM
    J Clin Invest; 1972 Dec; 51(12):3094-103. PubMed ID: 4344994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effect of a thymic epithelial culture supernate or thymosin fraction 5 on rabbit platelet aggregation and intracellular cyclic AMP levels.
    Hashimoto S; Itoh Y; Kawaguchi A; Mizuno Y; Muraoka M; Tsuchiya M
    J Cell Physiol; 1987 Dec; 133(3):499-506. PubMed ID: 2826498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bubble-induced aggregation of platelets: effects of gas species, proteins, and decompression.
    Thorsen T; Klausen H; Lie RT; Holmsen H
    Undersea Hyperb Med; 1993 Jun; 20(2):101-19. PubMed ID: 8392414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation: its relation with ADP-induced fibrinogen binding to platelets and ADP-related membrane enzyme activities.
    Legrand C; Dubernard V; Caen J
    Eur J Biochem; 1984 Aug; 142(3):465-71. PubMed ID: 6088225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation.
    Frojmovic MM; Mooney RF; Wong T
    Biophys J; 1994 Nov; 67(5):2069-75. PubMed ID: 7858144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia impairs agonist-induced integrin α
    Kiouptsi K; Gambaryan S; Walter E; Walter U; Jurk K; Reinhardt C
    Sci Rep; 2017 Aug; 7(1):7621. PubMed ID: 28790378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.